期刊文献+

血脑屏障渗透模型PAMPA的构建及其条件优化 被引量:1

Model Establishment and Optimized Conditions of PAMPA for Blood-Brain Barrier
下载PDF
导出
摘要 平行人工膜渗透模型(parallel artificial membrane permeation assay,PAMPA)主要以人工磷脂作为生物膜来模拟药物跨膜的屏障,能测定通过被动扩散途径跨过血脑屏障的药物,该模型操作简单,成本低。以实验室合成的化合物为研究对象,在MultiScreen~■ 96-well板上铺一层牛脑磷脂的十二烷溶液作为PAMPA模型,并通过高效液相色谱(HPLC)测定化合物的血脑屏障渗透率。实验中发现亲脂性化合物水溶性较差,需要添加助溶剂以帮助溶解,因此考察了4种助溶剂(DMSO、乙腈、乙醇、正丙醇)对化合物溶解度的影响及助溶剂含量对磷脂膜完整性的影响,最终选择了浓度为10%的正丙醇做为助溶剂来进行渗透实验,测得了各个化合物的渗透率,并筛选出了渗透率最好的化合物,为将来的药物开发提供指导。 Parallel artificial membrane permeation assay(PAMPA) mainly uses artificial phospholipids as biofilm to simulate the barrier of drug transmembrane, and can measure drugs that cross the blood-brain barrier through passive diffusion. The model is simple in operation and low in cost. In this study, a laboratory-synthesized compound was used as a research object. A layer of bovine brain phospholipid dodecane solution was applied to the MultiScreen ■ 96-well plate as a PAMPA model, and the Blood-Brain Barrier Permeability of the compound was determined by high performance liquid chromatography(HPLC). In the experiment, it was found that the lipophilic of four cosolvents(DMSO, acetonitrile, ethanol, n-propanol) on the solubility of the compound and compound was poorly water-soluble. To solve this problem, this experiment investigated the effects of the concentration of the cosolvent on the integrity of the phospholipid membrane. The effect was chosen to select the best cosolvent for the penetration test of the Blood-Brain Barrier penetration model PAMPA.
作者 付莹 吕金鹏 李文建 丁淑敏 柳丽 宋国强 FU Ying;LYU Jinpeng;LI Wenjian;DING Shumin;LIU Li;SONG Guoqiang(School of Pharmaceutical Engineering & Life Sciences, Changzhou University, Changzhou 213164,China)
出处 《常州大学学报(自然科学版)》 CAS 2019年第4期86-92,共7页 Journal of Changzhou University:Natural Science Edition
基金 国家自然科学基金资助项目(81603336)
关键词 平行人工膜渗透模型 血脑屏障 助溶剂 磷脂膜 渗透率 parallel artificial membrane permeation model Blood-Brain Barrier cosolvent phospholipid film permeability
  • 相关文献

参考文献5

二级参考文献61

  • 1孙晶晶,谢林,梁艳,张冬梅,刘晓东.LC-MS测定大鼠脑微血管内皮细胞中卡马西平的含量[J].中国药科大学学报,2005,36(3):241-244. 被引量:3
  • 2都本敏,荆进红.川芎嗪的临床应用[J].现代中西医结合杂志,2006,15(10):1398-1399. 被引量:26
  • 3姚鹏,黄杰,康春生,浦佩玉,常津.跨血脑屏障复合功能纳米载体系统的构建[J].中国医学科学院学报,2006,28(4):481-485. 被引量:11
  • 4韩旻,傅韶,方晓玲.三七总皂苷油包水微乳的处方筛选及体内外评价[J].药学学报,2007,42(7):780-786. 被引量:27
  • 5Smith M,Omidi Y,Gumbleton M.Primary porcine brain microvascular endothelial cells:biochemical and functional characterisation as a model for drug transport and targeting[J].J Drug Target,2007,15(4):253-268.
  • 6Pastan I,Gottesman MM,Ueda K,et al.A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells[J].Proc Natl Acad Sci USA,1988,85(12):4486-4490.
  • 7Mahajan SD,Aalinkeel R,Sykes DE,et al.Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression:Implication for HIV-1 neuropathogenesis in the context of drug abuse[J].Brain Res,2003:133-148.
  • 8Jallouli Y,Paillard A,Chang J,et al.Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro[J].Int J Pharm,2007,344(1-2):103-109.
  • 9Garcia-Garcia E,Gil S,Andrieux K,et al.A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles[J].Cell Mol Life Sci,2005,62(12):1400-1408.
  • 10Culot M,Lundquist S,Vanuxeem D,et al.An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening[J].Toxicol In Vitro,2008,22(3):799-811.

共引文献19

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部